Which has the lower trailing P/E, GSK or MCK?

GSK has the lower trailing P/E: GSK trades at 15.59 and MCK at 23.14. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GSK or MCK?

Over the past five years, MCK grew revenue faster — GSK at a 1.38% CAGR versus MCK at 10.88%.

Does GSK or MCK pay a bigger dividend?

GSK yields 3.78% and MCK yields 0.37% based on trailing dividends and the latest price.

Is GSK or MCK more profitable?

GSK runs the higher net margin — GSK at 14.52% versus MCK at 1.12%.

How have GSK and MCK total returns compared?

Over the past 10 years, GSK delivered 6.11% and MCK delivered 18.37% annualized total return. Past performance doesn't predict future results.

GSK plc (GSK) vs McKesson Corporation (MCK)

A side-by-side comparison of GSK plc and McKesson Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

GSK

GSK plc

$98.82B

$49.33HealthcareDelayed quote: Sep 25, 2026, 3:50 PM EDT

MCK

McKesson Corporation

$101.22B

$864.59HealthcareDelayed quote: Sep 25, 2026, 3:45 PM EDT

Total return — GSK vs MCK

growth of $100 · dividends reinvested · last 10y

GSK +76.2% (+5.8%/yr)MCK +472.6% (+19.1%/yr)MCK compounded faster over this window

GSK MCK

GSK vs MCK: by the numbers

•MCK is the larger company ($101.22B vs $98.82B market cap).
•GSK trades at the lower trailing earnings multiple (15.59 vs 23.14 P/E), one valuation lens rather than an overall verdict.
•GSK converts more revenue to profit (14.52% vs 1.12% net margin).
•MCK grew revenue faster over the past five years (10.88% vs 1.38% CAGR).
•GSK pays the higher dividend yield (3.78% vs 0.37%).

Metrics side by side

Valuation

Metric	GSK	MCK
P/E ratio	15.59	23.14
Forward P/E	N/A	19.37
P/S ratio	2.23	0.25
P/B ratio	4.25	N/A
EV / EBITDA	7.98	14.52
FCF yield	9.44%	6.11%

Profitability

Metric	GSK	MCK
Gross margin	72.71%	3.64%
Operating margin	20.72%	1.62%
Net margin	14.52%	1.12%
ROE	27.67%	N/A
ROIC	13.95%	28.34%

Dividends

Metric	GSK	MCK
Dividend yield	3.78%	0.37%
Payout ratio	57.45%	8.78%

Growth (annualized)

Metric	GSK	MCK
Revenue CAGR (5Y)	1.38%	10.88%
EPS CAGR (5Y)	-0.71%	40.71%
FCF CAGR (5Y)	-2.45%	13.40%
Total return CAGR (5Y)	8.21%	34.85%

Frequently asked

Which has the lower trailing P/E, GSK or MCK?: GSK has the lower trailing P/E: GSK trades at 15.59 and MCK at 23.14. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GSK or MCK?: Over the past five years, MCK grew revenue faster — GSK at a 1.38% CAGR versus MCK at 10.88%.
Does GSK or MCK pay a bigger dividend?: GSK yields 3.78% and MCK yields 0.37% based on trailing dividends and the latest price.
Is GSK or MCK more profitable?: GSK runs the higher net margin — GSK at 14.52% versus MCK at 1.12%.
How have GSK and MCK total returns compared?: Over the past 10 years, GSK delivered 6.11% and MCK delivered 18.37% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GSK analysis Full MCK analysis Interactive comparison tool

Dig into the metrics

GSK P/E ratio McKesson P/E ratio GSK dividend yield McKesson dividend yield GSK ROE McKesson ROE GSK operating margin McKesson operating margin GSK revenue growth McKesson revenue growth GSK free cash flow McKesson free cash flow

GSK & McKesson appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.